blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1392682

EP1392682 - HETEROCYCLYLALKOXY-, -ALKYLTHIO- AND -ALKYLAMINOBENZAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.03.2009
Database last updated on 01.02.2025
Most recent event   Tooltip27.03.2009Application deemed to be withdrawnpublished on 29.04.2009  [2009/18]
Applicant(s)For all designated states
Wyeth
Five Giralda Farms
Madison, NJ 07940 / US
[N/P]
Former [2004/10]For all designated states
Wyeth
Five Giralda Farms
Madison, New Jersey 07940 / US
Inventor(s)01 / LI, Yanfang
3 Woodlane Road
Lawrenceville, NJ 08648 / US
02 / ZHOU, Ping
28 Marion Drive
Plainsboro, NJ 08536 / US
 [2004/10]
Representative(s)Wileman, David Francis
Wyeth Pharmaceuticals, Patent Department, Huntercombe Lane South, Taplow, Maidenhead
Berkshire SL6 OPH / GB
[N/P]
Former [2004/10]Wileman, David Francis Dr.
Wyeth Pharmaceuticals, Patent Department, Huntercombe Lane South, Taplow
Maidenhead, Berkshire SL6 OPH / GB
Application number, filing date02736592.319.04.2002
[2004/10]
WO2002US12512
Priority number, dateUS20010285644P20.04.2001         Original published format: US 285644 P
[2004/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02085853
Date:31.10.2002
Language:EN
[2002/44]
Type: A2 Application without search report 
No.:EP1392682
Date:03.03.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 31.10.2002 takes the place of the publication of the European patent application.
[2004/10]
Search report(s)International search report - published on:EP19.12.2002
ClassificationIPC:C07D403/12, A61K31/44, A61P25/00
[2004/10]
CPC:
C07D401/14 (EP,US); C07D403/12 (EP,KR,US); A61P25/00 (EP);
A61P25/16 (EP); A61P25/22 (EP); A61P25/28 (EP);
A61P43/00 (EP); C07D207/06 (EP,US); C07D409/14 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/10]
Extension statesAL06.10.2003
LT06.10.2003
LV06.10.2003
MK06.10.2003
RO06.10.2003
SI06.10.2003
TitleGerman:HETEROZYKLYLALKOXY-, -ALKYLTHIO- UND ALKYLAMINOBENZAZOLDERIVATE ALS 5-HYDROXYTRYPTAMIN-6-LIGANDEN[2004/10]
English:HETEROCYCLYLALKOXY-, -ALKYLTHIO- AND -ALKYLAMINOBENZAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS[2004/10]
French:DERIVES DE HETEROCYCLYLALCOXY-, -ALKYLTHIO- ET -ALKYLAMINOBENZAZOLE EN TANT QUE LIGANDS DE LA 5-HYDROXYTRYPTAMINE-6[2004/10]
Entry into regional phase06.10.2003National basic fee paid 
06.10.2003Designation fee(s) paid 
06.10.2003Examination fee paid 
Examination procedure04.11.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
06.10.2003Examination requested  [2004/10]
07.10.2003Amendment by applicant (claims and/or description)
03.11.2008Application deemed to be withdrawn, date of legal effect  [2009/18]
10.12.2008Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2009/18]
Fees paidRenewal fee
06.04.2004Renewal fee patent year 03
04.04.2005Renewal fee patent year 04
27.03.2006Renewal fee patent year 05
10.04.2007Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.04.200807   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO9503298  (FUJISAWA PHARMACEUTICAL CO [JP], et al) [Y] 1-9,15-20 * claim 1 *;
 [Y]US6054469  (BOURRAIN SYLVIE [GB], et al) [Y] 1-9,15-20* claim 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.